Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE-Filo-1
PACTR202510883361706Phase 1Not yet recruiting
- Sponsor
- Infectious Diseases Institute
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 3
01
Overview
Phase 1 trial of obeldesivir and galidesivir in Ebola virus disease (EVD) (2 arms), sponsored by Infectious Diseases Institute. Planned start May 2026; status: not yet recruiting.
02
Drugs
obeldesivirgalidesivir
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR202510883361706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202510883361706.